Articles
-
First CADIFA certification from ANVISA for Etodolac
Learn more: First CADIFA certification from ANVISA for EtodolacFirst CADIFA certification from ANVISA for Etodolac In the dynamic landscape of pharmaceutical regulations, Brazil…
-
Another Polpharma API strategic milestone achieved!
Learn more: Another Polpharma API strategic milestone achieved!KiloLab Laboratory – a development and production in a kilogram scale – has been launched,…
-
Ryvu Therapeutics and Polpharma sign two agreements in the area of RVU120 active substance (API) production for Phase II clinical trials
Learn more: Ryvu Therapeutics and Polpharma sign two agreements in the area of RVU120 active substance (API) production for Phase II clinical trialsRyvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small…
-
Cryogenic infrastructure at API facility
Learn more: Cryogenic infrastructure at API facilityCold manufacturing Cryochemistry is the study of chemical interactions at temperatures below −150 °C (−238 °F; 123 K). It is derived…
-
Liophilization: What does a strawberry have in common with Polpharma API?
Learn more: Liophilization: What does a strawberry have in common with Polpharma API?On November 2022, at Polpharma API Plant, we implemented freeze-drying machine! Crunchy habits It has…
-
Polpharma’s strategic investment in HPAPI facility, the first of this kind in Poland
Learn more: Polpharma’s strategic investment in HPAPI facility, the first of this kind in PolandIn 2022, we are opening a new chapter in the history of Polpharma in the…
